English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Apr 20, 2026

Study finds older immigrants in Finland face barriers to healthcare and employment
+ Pharmaceuticals
Patient Daily | Apr 20, 2026

University of Cincinnati begins clinical trial for new prosthetic joint infection drug
+ Pharmaceuticals
Patient Daily | Apr 20, 2026

FDA clears investigational new drug application to test sCAR-T therapy for autoimmune conditions
+ Pharmaceuticals
Patient Daily | Apr 20, 2026

Study finds 12-item questionnaire effective for assessing health literacy in Finnish adults
+ Pharmaceuticals
Patient Daily | Apr 20, 2026

Eli Lilly launches Foundayo obesity pill following FDA approval
+ Pharmaceuticals
Patient Daily | Apr 20, 2026

FDA rejects Replimune’s advanced melanoma drug for second time in April decision
+ Pharmaceuticals
Patient Daily | Apr 20, 2026

FDA reviews safety of abortion pill mifepristone after court ruling on mail access
+ Pharmaceuticals
Patient Daily | Apr 20, 2026

Researchers develop embodied AI system to guide users through unfamiliar physical tasks

Trending
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
+ Pharmaceuticals
Patient Daily | Aug 7, 2026

Researchers develop computer model linking brain chemistry to neural activity patterns